Ligustrazine alleviates acute pancreatitis by accelerating acinar cell apoptosis at early phase via the suppression of p38 and Erk MAPK pathways

This publication has 21 references indexed in Scilit:

• Protective effects of Ligustrazine, Kakonein and Panax Notoginsenoside on the small intestine and immune organs of rats with severe acute pancreatitis
  Hepatobiliary & Pancreatic Diseases International, 2011
• Ligustrazine improves atherosclerosis in rat via attenuation of oxidative stress
  Pharmaceutical Biology, 2011
• Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial
  The Lancet, 2008
• Induction of Apoptosis by Crambene Protects Mice against Acute Pancreatitis via Anti-Inflammatory Pathways
  The American Journal of Pathology, 2007
• Effect and Mechanism of Ligustrazine on Th1/Th2 Cytokines in a Rat Asthma Model
  The American Journal of Chinese Medicine, 2007
• In Vitro Evidence for Role of ERK, p38, and JNK in Exocrine Pancreatic Cytokine Production
  Journal of Gastrointestinal Surgery, 2006
• Practice Guidelines in Acute Pancreatitis
  American Journal of Gastroenterology, 2006
• Involvement of intracellular and extracellular Ca²⁺ in tetramethylpyrazine‐induced colonic anion secretion
  Cell Biology International, 2006
• ACUTE PANCREATITIS: MODELS, MARKERS, AND MEDIATORS
  Shock, 2005
• Apoptosis versus necrosis in acute pancreatitis
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2004